Cutting edge: IL-12 and IL-18 differentially regulate the transcriptional activity of the human IFN-γ promoter in primary CD4+ T lymphocytes

Journal of Immunology

Volumn 160, Issue 8, 1998, Pages 3642-3647

  Barbulescu, Karina ^a   Becker, Christoph ^a   Schlaak, Jörg F ^a   Schmitt, Edgar ^a   Meyer Zum Büschenfelde, Karl Hermann ^a   Neurath, Markus F ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; RECOMBINANT INTERLEUKIN 12; RECOMBINANT INTERLEUKIN 18; STAT4 PROTEIN; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; CYTOKINE; DNA BINDING PROTEIN; INTERLEUKIN 18; PRIMER DNA; STAT4 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

ARTICLE; BINDING SITE; CELL DIFFERENTIATION; DNA FOOTPRINTING; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; NORMAL HUMAN; PRIORITY JOURNAL; PROMOTER REGION; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION; BIOLOGICAL MODEL; BIOSYNTHESIS; CD4+ T LYMPHOCYTE; CELL CULTURE; DRUG EFFECT; GENETIC TRANSFECTION; GENETICS; IMMUNOLOGY; METABOLISM; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; SITE DIRECTED MUTAGENESIS; TRANSACTIVATION;

BASE SEQUENCE; BINDING SITES; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOKINES; DNA FOOTPRINTING; DNA PRIMERS; DNA-BINDING PROTEINS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-18; MODELS, BIOLOGICAL; MUTAGENESIS, SITE-DIRECTED; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); STAT4 TRANSCRIPTION FACTOR; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTOR AP-1; TRANSFECTION;

EID: 0032521933     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Trinchieri, G. 1995. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251.
2. 4+ T cells occurs through macrophage production of IL-12. Science 260:547.
3. Wolf, S. F., P. A. Temple, M. Kobayashi, D. Young, M. Dicig, L. Lowe, R. Dziabo, L. Fitz, C. Ferenz, R. M. Hewick, K. Kelleher, S. H. Chan, G. Trinchieri, and B. Perussia. 1991. Cloning of cDNA for natural killer cell stimulation factor, a heterodimeric cytokine with multiple biological effects on T and natural killer cells. J. Immunol. 146:3074.
4. Wu, C., R. R. Warrier, X. Wang, D. H. Presky, and M. K. Gately. 1997. Regulation of interleukin-12 receptor beta 1 chain expression and interleukin-12 binding by human peripheral blood mononuclear cells. Eur. J. Immunol. 27:147.
5. Rogge, N., L. Barberis-Maino, M. Biffi, N. Passini, D. H. Presky, U. Gubler, and F. Singaglia. 1997. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J. Exp. Med. 185:825.
6. Szabo, S., A. S. Dighe, U. Gubler, and K. M. Murphy. 1997. Regulation of the interleukin (IL)-12R β2 subunit expression. J. Exp. Med. 185:817.
7. Jacobson, N. G., S. J. Szabo, R. M. Weber-Nordt, Z. Zhong, R. D. Schreiber, J. E. Darnell, Jr., and K. M. Murphy. 1995. Interleukin 12 signalling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (stat)3 and (stat)4. J. Exp. Med. 181:1755.
8. Thierfelder, W. E., J. M. van Deursen, K. Yamamoto, R. A. Tripp, S. R. Sarawar, R. T. Carson, M. Y. Sangster, D. A. Vignali, P. C. Doherty, G. C. Grosveld, and J. N. Ihle. 1996. Requirement for STAT4 in interleukin-12-mediated responses of natural killer and T cells. Nature 382:171.
9. Kaplan, M. H., Y. L. Sun, T. Heey, and M. J. Grusby. 1996. Impaired IL-12 responses and enhanced development of Th2 cells in STAT4 deficient mice. Nature 382:174.
10. Magram, J., S. E. Connaughton, R. R. Warrier, D. Carvajal, C. Wu, J. Ferrante, C. Stewart, U. Sarmiento, D. A. Faherty, and M. K. Gately. 1996. IL-12-deficient mice are defective in IFN-gamma production and type 1 cytokine responses. Immunity 4:471.
11. Ushio, S., M. Namba, O. Takanori, K. Hattori, Y. Nukada, K. Akita, F. Tanabe, K. Konishi, M. Micallef, M. Fujii, K. Torigoe, T. Tanimoto, S. Fukuda, M. Ikeda, H. Okamura, and M. Kurimoto. 1996. Cloning of the cDNA for human IFN-γ-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J. Immunol. 156:4274.
12. Okamura, H., T. Tsutsui, T. Komatsu, M. Yutsudo, A. Hakura, T. Tanimoto, K. Torigoe, T. Okura, Y. Nukada, K. Harttori, K. Akita, M. Namba, F. Tanabe, K. Konishi, S. Fukuda, and M. Kurimoto. 1995. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 378:88.
13. Robinson, D., K. Shibuya, A. Mui, F. Zonin, E. Murphy, T. Sana, S. B. Hartley, S. Menon, R. Kastelein, F. Bazan, and A. Ogarra. 1997. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-γ production and activates IRAK and NFκB. Immunity 7:571.
14. Barbulescu K., K.-H. Meyer zum Büschenfelde, and M. F Neurath. 1997. Constitutive and inducible protein/DNA interactions of the interferon-γ promoter in vivo in CD45RA and CD45RO T helper subsets. Eur. J. Immunol. 27:1098.
15. Neurath, M. F., E. E. Max, and W. Strober. 1995. Pax5 (BSAP) regulates the murine immunoglobulin 3′α enhancer by affecting binding of NF-αP, a protein that controls heavy chain transcription. Proc. Natl. Acad. Sci. USA 92:5336.
16. Neurath, M. P., S. Pettersson, K.-H. Meyer zum Büschenfelde, and W. Strober. 1996. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-κB abrogates experimental colitis in mice. Nat. Med. 2:998.
17. Ye, J., P. Ghosh, M. Cipitelli, J. Subleski, K. J. Hardy, J. R. Ortaldo, and H. A. Young. 1994. Characterization of a silencer regulatory element in the human interferon-gamma promoter. J. Biol. Chem. 269:25728.
18. Rincon, M., and R. A. Flavell. 1994. AP-1 transcriptional activity requires both T-cell receptor-mediated and co-stimulatory signals in primary T lymphocytes. EMBO J. 13:4370.
19. Neurath, M. F., I. Fuss, B. L. Kelsall, E. Stuber, and W. Strober. 1995. Antibodies to IL-12 abrogate established experimental colitis in mice. J. Exp. Med. 180: 1280.
20. Ye, J., J. R. Ortaldo, K. Conlon, R. Winkler-Pickett, and H. A. Young. 1995. Cellular and molecular mechanisms of IFN-gamma production induced by IL-2 and IL-12 in a human NK cell line. J. Leukocyte Biol. 58:225.
21. Penix, L., W. M. Weaver, Y. Pang, H. A. Young, and C. B. Wilson. 1993. Two essential regulatory elements in the human interferon gamma promoter confer activation specific expression in T cells. J. Exp. Med. 178:1483.
22. Sica, A., L. Dorman, V. Viggiano, M. Cippitelli, P. Ghosh, N. Rice, H. and A. Young. 1997. Interaction of NF-kappaB and NFAT with the interferon-gamma promoter. J. Biol. Chem. 373:30412.
23. + T cells and CD8 T cells. Mol. Cell Biol. 17:199.
24. Xu, X., Y.-L. Sun, and T. Hoey. 1996. Cooperative DNA binding and sequence-selective recognition conferred by the stat amino-terminal domain. Science 273: 794.
25. Ye, J., M. Cipitelli, L. Dorman, J. R. Ortaldo, and H. A. Young. 1996. The nuclear factor YY1 suppresses the human gamma interferon promoter through two mechanisms: inhibition of AP-1 binding and activation of a silencer element. Mol. Cell. Biol. 58:225.